Acute Leukemia

Categories: Blood diseases, Bone diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Acute Leukemia

MalaCards integrated aliases for Acute Leukemia:

Name: Acute Leukemia 39 12 30 56 15 17 74
Acute Undifferentiated Leukemia 74
Undifferentiated Leukemia 74
Stem Cell Leukaemia 12
Stem Cell Leukemia 12


External Ids:

Disease Ontology 12 DOID:12603
ICD9CM 36 208.0
NCIt 51 C9300
SNOMED-CT 69 24072005 91855006
ICD10 34 C95.0 C95.00

Summaries for Acute Leukemia

Disease Ontology : 12 A leukemia that occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia [ALL]) or myeloid cells (acute myelocytic leukemia [AML]) proliferate abnormally, replacing normal marrow tissue and hematopoietic cells and inducing anemia, thrombocytopenia, and granulocytopenia.

MalaCards based summary : Acute Leukemia, also known as acute undifferentiated leukemia, is related to megakaryocytic leukemia and childhood leukemia. An important gene associated with Acute Leukemia is BAALC (BAALC Binder Of MAP3K1 And KLF4), and among its related pathways/superpathways are Endometrial cancer and Pathways in cancer. The drugs Arsenic trioxide and Amphotericin B have been mentioned in the context of this disorder. Affiliated tissues include myeloid, bone and bone marrow, and related phenotypes are no effect and Reduced mammosphere formation

Wikipedia : 77 Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original... more...

Related Diseases for Acute Leukemia

Diseases in the Leukemia family:

Acute Leukemia Chronic Leukemia
Subacute Leukemia

Diseases related to Acute Leukemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 454)
# Related Disease Score Top Affiliating Genes
1 megakaryocytic leukemia 32.5 JAK2 MPO RUNX1
2 childhood leukemia 32.5 ETV6 KMT2A MLLT3 MTHFR RUNX1
3 acute lymphocytic leukemia 32.4 CSF3 ETV6 GSTM1 MTHFR RUNX1
4 lymphoblastic lymphoma 32.3 DNTT KMT2A MPO
5 leukemia, acute lymphoblastic 32.3 AFF1 ANPEP DNTT ETV6 FLT3 KMT2A
7 acute promyelocytic leukemia 32.0 ANPEP CD34 CEBPA CSF3 FLT3 MPO
8 lymphocytic leukemia 30.9 DNTT ETV6 KMT2A RUNX1
9 leukemia, acute myeloid 30.7 AFF1 ANPEP BAALC CD34 CEBPA CSF3
10 myeloid leukemia 30.5 CEBPA CREBBP ETV6 FLT3 JAK2 KIT
11 lymphoid leukemia 30.3 ETV6 FLT3 JAK2 KMT2A
12 aplastic anemia 30.3 CD34 CSF3 FLT3 GSTM1
13 chronic myelomonocytic leukemia 30.2 ETV6 FLT3 JAK2 KIT RUNX1
14 myelodysplastic syndrome 30.2 ANPEP CD34 CEBPA CREBBP CSF3 DNTT
15 myeloma, multiple 30.1 CD34 CSF3 JAK2 KIT
16 8p11 myeloproliferative syndrome 30.0 FLT3 KIT RUNX1
17 chronic eosinophilic leukemia 29.9 FLT3 KIT WT1
18 cytogenetically normal acute myeloid leukemia 29.8 CEBPA FLT3 KMT2A WT1
19 acute erythroid leukemia 29.8 CEBPA JAK2
20 acute lymphoblastic leukemia, childhood 29.8 ETV6 GSTM1 MTHFR RUNX1
21 myeloid sarcoma 29.7 ANPEP DNTT FLT3 KIT KMT2A MPO
22 myelofibrosis 29.7 CD34 CSF3 FLT3 JAK2 KIT
23 lymphoma, non-hodgkin, familial 29.7 CD34 CSF3 DNTT JAK2
24 gastrointestinal stromal tumor 29.4 CD34 FLT3 KIT MTHFR
25 leukemia, chronic myeloid 28.9 CD34 CSF3 DNTT ETV6 FLT3 JAK2
26 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 28.7 CREBBP DNTT ETV6 FLT3 KIT KMT2A
27 precursor t-cell acute lymphoblastic leukemia 28.7 ANPEP CD34 DNTT ETV6 FLT3 KMT2A
28 bone marrow cancer 28.5 ANPEP CD34 CSF3 ETV6 FLT3 JAK2
29 acute leukemia of ambiguous lineage 12.4
30 chromosome 8p11 myeloproliferative syndrome 11.9
31 invasive aspergillosis 11.4
32 chronic leukemia 11.4
33 myeloproliferative neoplasm 11.4
34 myelodysplastic myeloproliferative cancer 11.1
35 severe congenital neutropenia 11.1
36 mthfr gene variant 11.1
37 hematopoietic stem cell transplantation 10.6
38 lymphoma 10.5
39 acute myeloid leukemia with t(9;11)(p22;q23) 10.5 KMT2A MLLT3
40 subacute myeloid leukemia 10.5 FLT3 JAK2
41 ring chromosome 21 10.5 ETV6 KMT2A
42 chromophobe renal cell carcinoma 10.5
43 renal oncocytoma 10.5
44 acute myeloblastic leukemia with maturation 10.5 FLT3 KIT
45 testicular gonadoblastoma 10.5 KIT WT1
46 b-cell childhood acute lymphoblastic leukemia 10.4 ETV6 RUNX1
47 acute myeloid leukemia with minimal differentiation 10.4 FLT3 MPO
48 nondisjunction 10.4 KIT MTHFR
49 blood coagulation disease 10.4 CSF3 JAK2 MTHFR
50 congenital mesoblastic nephroma 10.4 ETV6 KIT WT1

Comorbidity relations with Acute Leukemia via Phenotypic Disease Network (PDN):

Deficiency Anemia Neutropenia

Graphical network of the top 20 diseases related to Acute Leukemia:

Diseases related to Acute Leukemia

Symptoms & Phenotypes for Acute Leukemia

GenomeRNAi Phenotypes related to Acute Leukemia according to GeneCards Suite gene sharing:

# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 no effect GR00402-S-1 10.26 AFF1 ANPEP BAALC CD34 CEBPA CREBBP
2 Reduced mammosphere formation GR00396-S 9.17 CD34 CEBPA CSF3 ETV6 GSTM1 KMT2A

MGI Mouse Phenotypes related to Acute Leukemia:

47 (show all 14)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.38 AFF1 ANPEP CD34 CEBPA CREBBP CSF3
2 immune system MP:0005387 10.34 AFF1 ANPEP CD34 CEBPA CREBBP CSF3
3 homeostasis/metabolism MP:0005376 10.3 CD34 CEBPA CREBBP DNTT ETV6 FLT3
4 growth/size/body region MP:0005378 10.27 AFF1 CEBPA CREBBP ETV6 FLT3 JAK2
5 cardiovascular system MP:0005385 10.24 ANPEP CEBPA CREBBP ETV6 KIT KMT2A
6 endocrine/exocrine gland MP:0005379 10.21 AFF1 ANPEP CEBPA CREBBP ETV6 FLT3
7 integument MP:0010771 10.14 ANPEP CD34 CEBPA CREBBP CSF3 ETV6
8 embryo MP:0005380 10.13 CREBBP ETV6 JAK2 KIT KMT2A MLLT3
9 mortality/aging MP:0010768 10.13 AFF1 CEBPA CREBBP ETV6 FLT3 JAK2
10 liver/biliary system MP:0005370 9.97 CEBPA CREBBP JAK2 KIT KMT2A MTHFR
11 neoplasm MP:0002006 9.9 CD34 CEBPA CREBBP ETV6 FLT3 JAK2
12 muscle MP:0005369 9.8 CEBPA CREBBP KIT KMT2A MPO STMN1
13 no phenotypic analysis MP:0003012 9.65 AFF1 CEBPA ETV6 FLT3 KIT KMT2A
14 normal MP:0002873 9.32 CEBPA CREBBP DNTT ETV6 JAK2 KIT

Drugs & Therapeutics for Acute Leukemia

Drugs for Acute Leukemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 463)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Arsenic trioxide Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 1327-53-3 518740
Amphotericin B Approved, Investigational Phase 4,Phase 3,Phase 2 1397-89-3 5280965 14956
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 1177-87-3
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 2068-78-2, 57-22-7 5978
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 75607-67-9, 21679-14-1 30751
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 135968-09-1
Sargramostim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 123774-72-1, 83869-56-1
Cytarabine Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4, 65-46-3 6253
Busulfan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55-98-1 2478
Vidarabine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 24356-66-9 21704 32326
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-18-0, 6055-19-2 2907
Mycophenolic acid Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 24280-93-1 446541
Posaconazole Approved, Investigational, Vet_approved Phase 4,Phase 2 171228-49-2 147912
Micafungin Approved, Investigational Phase 4,Phase 2 235114-32-6 477468 3081921
17 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1
18 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
19 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
21 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1
22 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
24 Liposomal amphotericin B Phase 4,Phase 3,Phase 2
25 Anti-Bacterial Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
26 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
27 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
28 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
29 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
30 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Antimitotic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
32 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
33 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
35 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
36 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
37 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
protease inhibitors Phase 4,Phase 3,Phase 2,Phase 1
40 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 BB 1101 Phase 4,Phase 3,Phase 2,Phase 1
42 Antimetabolites Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
43 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
44 Adjuvants, Immunologic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 Antineoplastic Agents, Alkylating Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
46 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 Thymoglobulin Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Alkylating Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Immunologic Factors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
50 Antimetabolites, Antineoplastic Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 635)
# Name Status NCT ID Phase Drugs
1 Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic Unknown status NCT00196768 Phase 4 Arsenic trioxide;Trisenox
2 PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia Completed NCT00362544 Phase 4 Ambisome
3 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Completed NCT01200355 Phase 4 micafungin;posaconazole
4 Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) Completed NCT00504764 Phase 4 Arsenic Trioxide;ATRA
5 Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia Completed NCT00411541 Phase 4 vincristine;dexamethasone
6 Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation Not yet recruiting NCT02784561 Phase 4 Busulfan (Zhejiang Otsuka Pharmaceutical Co. Ltd);Cytarabine(Actavis Italy S.p.A);Fludarabine (Bayer);granulocyte colony-stimulating factor (KirinKunpeng);rabbit ATG(Sanofi/Genzyme)
7 Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia Not yet recruiting NCT03896971 Phase 4 Combination of thrombopoietin mimetic and cyclosporin A
8 A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT Not yet recruiting NCT03190733 Phase 4 ATG
9 Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Not yet recruiting NCT01339988 Phase 4 Busulfan/Cyclophosphamide
10 ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia Terminated NCT00386997 Phase 4 liposomal amphotericin B (AmBisome®)
11 Antifungal Prophylaxis in Pediatric Acute Leukemia Unknown status NCT00624143 Phase 3 ORAL VORICONAZOLE and IV Amphotericin B
12 A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission Unknown status NCT01067300 Phase 3
13 Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia Unknown status NCT02241031 Phase 2, Phase 3 thrombopoietin (TPO) and interleukin-11
14 MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT Unknown status NCT02673008 Phase 2, Phase 3
15 Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Unknown status NCT01809392 Phase 2, Phase 3 decitabine
16 Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation Unknown status NCT01800643 Phase 2, Phase 3
17 Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation Unknown status NCT01217723 Phase 3
18 Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: Unknown status NCT02070523 Phase 3 VDCLD regimen
19 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
20 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
21 Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma Unknown status NCT00003728 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;doxorubicin hydrochloride;etoposide;leucovorin calcium;mercaptopurine;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisolone;therapeutic hydrocortisone;thioguanine;vincristine sulfate;vindesine
22 Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children Completed NCT01385891 Phase 2, Phase 3 Clofarabine VP 16 ciclophospahamide
23 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Completed NCT01371656 Phase 3 levofloxacin
24 Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia Completed NCT00678275 Phase 3 ATG FRESENIUS (Anti-Lymphocyte-Globulin);ATG FRESENIUS (Anti-Lymphocyte-Globulin)
25 Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission Completed NCT00002534 Phase 3 cyclophosphamide;cytarabine;methylprednisolone;thiotepa
26 Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation Completed NCT01020175 Phase 3
27 Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen Completed NCT00774280 Phase 3 BuCy vs BuFlu
28 Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia Completed NCT00002700 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;mitoxantrone hydrochloride;prednisolone;prednisone;therapeutic hydrocortisone;vincristine sulfate
29 Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2 Completed NCT00931138 Phase 3 chemotherapy (Aracytine + Daunorubicin);chemotherapy (Aracytine + Daunorubicin);chemotherapy (Aracytine + Daunorubicin)
30 A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old Completed NCT00927498 Phase 3 conventional chemotherapy (AraC + Daunorubicin),;Mylotarg associated with conventional chemotherapy (AraC + Daunorubicin),
31 Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) Completed NCT00880243 Phase 3 GM-CSF
32 A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients Completed NCT00163722 Phase 3
33 Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Completed NCT00093990 Phase 3 Tipifarnib;Zarnestra; R115777
34 Timed-Sequential Induction in CBF-AML Completed NCT00428558 Phase 3 Chemotherapy (DAUNORUBICINE-CYTARABINE);Chemotherapy (DAUNORUBICINE-CYTARABINE)
35 Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia Completed NCT00046683 Phase 3 alemtuzumab
36 Prevention of Left Ventricular Dysfunction During Chemotherapy Completed NCT01110824 Phase 3 Enalapril and carvedilol
37 Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Completed NCT00557193 Phase 3 Asparaginase;Cyclophosphamide;Cytarabine;Daunorubicin Hydrochloride;Dexamethasone;Etoposide;Lestaurtinib;Leucovorin Calcium;Mercaptopurine;Methotrexate;Methylprednisolone;Pegaspargase;Prednisone;Therapeutic Hydrocortisone;Vincristine Sulfate
38 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
39 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
40 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
41 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
42 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
43 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
44 Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma Completed NCT00003187 Phase 2, Phase 3 cyclophosphamide;cyclosporine;cytarabine;methotrexate;methylprednisolone
45 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
46 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
47 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
48 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
49 Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT Recruiting NCT03596892 Phase 2, Phase 3 Decitabine;Busulfan (BU);Cyclophosphamide (CY)
50 Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia Recruiting NCT03799224 Phase 2, Phase 3 Decitabine;mBU/CY and ATG;mBU/CY

Search NIH Clinical Center for Acute Leukemia

Cell-based therapeutics:

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Acute Leukemia cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Acute Leukemia:
Promostem, mesenchymal stem cells for treatment of graft-versus-host disease

Genetic Tests for Acute Leukemia

Genetic tests related to Acute Leukemia:

# Genetic test Affiliating Genes
1 Acute Leukemia 30

Anatomical Context for Acute Leukemia

MalaCards organs/tissues related to Acute Leukemia:

Myeloid, Bone, Bone Marrow, T Cells, B Cells, Liver, Nk Cells

Publications for Acute Leukemia

Articles related to Acute Leukemia:

(show top 50) (show all 3781)
# Title Authors Year
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia. ( 30614357 )
Early Deaths in Pediatric Acute Leukemia: A Major Challenge in Developing Countries. ( 30615014 )
Therapeutic granulocyte transfusions: neutropenic patients with acute leukemia continue to need them - why are definitive evidence-based practice guidelines elusive? ( 30615809 )
Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study. ( 30625391 )
Challenges in Clinical Metaproteomics Highlighted by the Analysis of Acute Leukemia Patients with Gut Colonization by Multidrug-Resistant Enterobacteriaceae. ( 30626002 )
Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study. ( 30626352 )
Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. ( 30626574 )
Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status. ( 30639430 )
Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study. ( 30649224 )
Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling. ( 30651113 )
Resolution of celiac disease, IgA deficiency and platelet refractoriness after allogeneic bone marrow transplantation for acute leukemia. ( 30655374 )
Mathematical models of amino acid panel for assisting diagnosis of children acute leukemia. ( 30674317 )
Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells. ( 30702467 )
Very rare lineage switch from acute myeloid leukemia to mixed phenotype acute leukemia, B/Myeloid, during chemotherapy with no clonal evolution. ( 30707502 )
Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells. ( 30733302 )
Long Non-Coding RNA and Acute Leukemia. ( 30744139 )
Analytical performance of automated platelet counts and impact on platelet transfusion guidance in patients with acute leukemia. ( 30761915 )
Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review. ( 30786841 )
'Acute leukemia in congenital methehemoglobinemia - an enigma to explore'. ( 30788079 )
Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of EBMT acute leukemia Working Party. ( 30792203 )
Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study. ( 30824955 )
Audit of Quality and Quantity of Nucleic Acid Yield from Pediatric Acute Leukemia Cases Following a Bio-banking Initiative. ( 30828152 )
Mixed Phenotype Acute Leukemia, B/Myeloid with t(9;22): Diagnostic and Therapeutic Challenges. ( 30828170 )
Psychosocial Experiences of Young Adults Diagnosed With Acute Leukemia During Hospitalization for Induction Chemotherapy Treatment. ( 30829935 )
Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant. ( 30836977 )
Lipodystrophy-like features after total body irradiation among survivors of childhood acute leukemia. ( 30844749 )
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience. ( 30858955 )
ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine. ( 30860475 )
Acute leukemia in a patient with 15q overgrowth syndrome. ( 30861314 )
Identification of chromosomal abnormalities and genomic features in near-triploidy/tetraploidy-acute leukemia by fluorescence in situ hybridization. ( 30863166 )
Checkpoint inhibition of PD-L1 and CTLA-4 in a child with refractory acute leukemia. ( 30863527 )
High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS). ( 30864117 )
Mixed-phenotype acute leukemia with t(4;11)(q21;q23) KMT2A-AFF1-rearranged. ( 30872272 )
Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis. ( 30880638 )
Ophthalmic Manifestations of Acute Leukemia. ( 30891378 )
Association between NAT2 polymorphisms and acute leukemia risk: A meta-analysis. ( 30896661 )
Staging of acute leukemia based on central nervous system involvement alone: Is it appropriate? ( 30900807 )
Nasal embryonal rhabdomyosarcoma with bone marrow metastasis simulating acute leukemia: A case report and review of the literature. ( 30902383 )
Treatment of venous thromboembolism in acute leukemia: A systematic review. ( 30921533 )
Xiao W, Bharadwaj M, Levine M, et al. PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation. Blood Adv. 2018;2(23):3526-3539. ( 30926597 )
Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia? ( 30927969 )
A novel thiosemicarbazone as a promising effective and selective compound for acute leukemia. ( 30932944 )
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia. ( 30952616 )
Corrigendum to 'Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study' [Biology of Blood and Marrow Transplantation 23/8 (2017) 1303-1310]. ( 30953638 )
Corrigendum to 'Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation' [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947]. ( 30954498 )
Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome. ( 30956966 )
18F-FDG PET/CT for extramedullary relapse of acute leukemia of ambiguous lineage. ( 30967343 )
Cytomegalovirus Retinitis in Children and Adolescents with Acute Leukemia following allogeneic Hematopoietic Stem Cell Transplantation. ( 30972869 )
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT. ( 30979868 )
Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia. ( 30988420 )

Variations for Acute Leukemia

Expression for Acute Leukemia

Search GEO for disease gene expression data for Acute Leukemia.

Pathways for Acute Leukemia

GO Terms for Acute Leukemia

Biological processes related to Acute Leukemia according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 cell differentiation GO:0030154 9.92 ANPEP ETV6 FLT3 JAK2 STMN1
2 positive regulation of transcription, DNA-templated GO:0045893 9.85 CEBPA CREBBP KMT2A MLLT3 RUNX1 WT1
3 positive regulation of DNA-binding transcription factor activity GO:0051091 9.72 CSF3 JAK2 KIT
4 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.65 FLT3 JAK2 KIT
5 cytokine-mediated signaling pathway GO:0019221 9.65 CEBPA CSF3 FLT3 JAK2 KIT
6 embryonic hemopoiesis GO:0035162 9.54 KIT KMT2A
7 regulation of myeloid cell differentiation GO:0045637 9.51 CREBBP RUNX1
8 transcription by RNA polymerase II GO:0006366 9.5 CEBPA KMT2A MLLT3
9 granulocyte differentiation GO:0030851 9.49 CEBPA CSF3
10 hemopoiesis GO:0030097 9.46 CD34 FLT3 KIT RUNX1
11 myeloid progenitor cell differentiation GO:0002318 9.4 FLT3 KIT
12 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.26 CSF3 FLT3 JAK2 KIT
13 hematopoietic stem cell proliferation GO:0071425 8.8 CD34 ETV6 RUNX1
14 regulation of transcription, DNA-templated GO:0006355 10.03 AFF1 CEBPA CREBBP ETV6 KMT2A MLLT3
15 positive regulation of transcription by RNA polymerase II GO:0045944 10 CEBPA CREBBP CSF3 ETV6 KMT2A RUNX1

Molecular functions related to Acute Leukemia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transcription regulatory region DNA binding GO:0044212 9.26 CEBPA KMT2A RUNX1 WT1
2 lysine-acetylated histone binding GO:0070577 9.16 KMT2A MLLT3
3 DNA-binding transcription factor activity GO:0003700 9.1 AFF1 CEBPA ETV6 KMT2A RUNX1 WT1

Sources for Acute Leukemia

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
33 HPO
34 ICD10
35 ICD10 via Orphanet
39 LifeMap
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
56 Novoseek
59 OMIM via Orphanet
63 PubMed
71 SNOMED-CT via Orphanet
73 Tocris
75 UMLS via Orphanet
Loading form....